Picture of Biotricity logo

BTCY — Biotricity News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Biotricity Inc reports results for the quarter ended in September - Earnings Summary

* Biotricity Inc  BTCY.OQ  reported a quarterly adjusted
loss of 9
cents​​ per share for the quarter ended in September. The mean
expectation of four analysts for the quarter was for a loss of 7
cents per share.
    * Revenue rose 31.7% to $2.38 million from a year ago;
analysts
expected $2.54 million. 
    * Biotricity Inc's reported EPS for the quarter was a loss
of 9
cents​.
    * The mean earnings estimate of analysts had risen by
about 36.2%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Biotricity Inc shares had risen by 27.5% this quarter and
lost 74.4% so far this year.
    * The company reported a quarterly loss of $4.9 million.
    * Wall Street's median 12-month price target for Biotricity
Inc is
$3.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 10:04 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.07          -0.09          Missed
 Jun. 30 2022      -0.11          -0.10          Beat
 Mar. 31 2022      -0.11          -0.11          Met
 Dec. 31 2021      -0.16          -0.12          Beat

Recent news on Biotricity

See all news